JP2009035530A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009035530A5 JP2009035530A5 JP2008129762A JP2008129762A JP2009035530A5 JP 2009035530 A5 JP2009035530 A5 JP 2009035530A5 JP 2008129762 A JP2008129762 A JP 2008129762A JP 2008129762 A JP2008129762 A JP 2008129762A JP 2009035530 A5 JP2009035530 A5 JP 2009035530A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide
- oligonucleotide
- immunostimulatory oligonucleotide
- deaza
- thio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 108091034117 Oligonucleotide Proteins 0.000 claims 3
- 230000003308 immunostimulating effect Effects 0.000 claims 2
- SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 claims 1
- LUCHPKXVUGJYGU-XLPZGREQSA-N 5-methyl-2'-deoxycytidine Chemical compound O=C1N=C(N)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 LUCHPKXVUGJYGU-XLPZGREQSA-N 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93058007P | 2007-05-17 | 2007-05-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009035530A JP2009035530A (ja) | 2009-02-19 |
| JP2009035530A5 true JP2009035530A5 (enExample) | 2011-06-30 |
Family
ID=39720158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008129762A Pending JP2009035530A (ja) | 2007-05-17 | 2008-05-16 | 免疫刺激能を有するクラスａオリゴヌクレオチド |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20100285041A1 (enExample) |
| EP (1) | EP2160199A2 (enExample) |
| JP (1) | JP2009035530A (enExample) |
| KR (1) | KR20100010509A (enExample) |
| CN (1) | CN101678098A (enExample) |
| AR (1) | AR066626A1 (enExample) |
| AU (1) | AU2008252577A1 (enExample) |
| BR (1) | BRPI0811621A2 (enExample) |
| CA (1) | CA2687441A1 (enExample) |
| IL (1) | IL202096A0 (enExample) |
| MX (1) | MX2009012482A (enExample) |
| RU (1) | RU2009142211A (enExample) |
| TW (1) | TW200916115A (enExample) |
| WO (1) | WO2008142509A2 (enExample) |
| ZA (1) | ZA200908062B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030026782A1 (en) * | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US7276489B2 (en) * | 2002-10-24 | 2007-10-02 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| EP3006043B1 (en) | 2002-04-04 | 2019-05-29 | Zoetis Belgium S.A. | Immunostimulatory g,u-containing oligoribonucleotides |
| US20040053880A1 (en) | 2002-07-03 | 2004-03-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| AR040996A1 (es) | 2002-08-19 | 2005-04-27 | Coley Pharm Group Inc | Acidos nucleicos inmunoestimuladores |
| SI2241325T1 (sl) | 2002-10-29 | 2012-05-31 | Coley Pharm Group Inc | Uporaba CPG oligonukleotidov pri zdravljenju okužbe z virusom hepatitisa C |
| BRPI0416079A (pt) | 2003-10-30 | 2007-01-02 | Coley Pharm Gmbh | análogos de oligonucleotìdeos de classe c com uma potência imunoestimuladora aumentada |
| KR101251707B1 (ko) | 2006-09-27 | 2013-04-11 | 콜리 파마슈티칼 게엠베하 | 면역 자극 활성이 증강된 소수성 Ｔ 유사체를 함유하는 ＣｐＧ 올리고뉴클레오티드 유사체 |
| CA2800158C (en) * | 2010-05-28 | 2020-07-21 | Coley Pharmaceutical Group, Inc. | Vaccines comprising cholesterol and cpg as sole adjuvant-carrier molecules |
| EP2471926A3 (en) * | 2010-12-30 | 2012-07-11 | Intervet International BV | Immunostimulatory oligodeoxynucleotides |
| KR102712879B1 (ko) * | 2012-07-13 | 2024-10-04 | 웨이브 라이프 사이언시스 리미티드 | 키랄 제어 |
| EP3238727B1 (en) * | 2014-12-25 | 2023-01-18 | National Institutes of Biomedical Innovation, Health and Nutrition | Non-aggregating immunostimulatory oligonucleotides |
| TW201639583A (zh) * | 2015-03-20 | 2016-11-16 | 國立研究開發法人醫藥基盤 健康 營養研究所 | 具有免疫賦活活性之含有ＣｐＧ－間隔基－寡核苷酸複合體及其用途 |
| US12246031B2 (en) | 2018-02-13 | 2025-03-11 | Checkmate Pharmaceuticals, Inc. | Compositions and methods for tumor immunotherapy |
| AU2019251421B2 (en) | 2018-04-09 | 2025-05-01 | Checkmate Pharmaceuticals | Packaging oligonucleotides into virus-like particles |
| WO2019240503A1 (ko) * | 2018-06-12 | 2019-12-19 | 주식회사 에이엠사이언스 | B형 간염 예방 또는 치료용 조성물 |
| WO2019240504A1 (en) * | 2018-06-12 | 2019-12-19 | Am Sciences Co., Ltd. | Modified oligonucleotides for inhibition of target gene expression |
| US20250376689A1 (en) * | 2021-08-31 | 2025-12-11 | City Of Hope | Oligonucleotides having 6-thio-2'-deoxyguanosine residues and uses thereof |
| CN113517062B (zh) * | 2021-09-14 | 2021-12-10 | 青岛未来移动医疗科技有限公司 | 一种智能疫苗雾化系统及使用方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) * | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US4469863A (en) * | 1980-11-12 | 1984-09-04 | Ts O Paul O P | Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof |
| US4675189A (en) * | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| US5023243A (en) * | 1981-10-23 | 1991-06-11 | Molecular Biosystems, Inc. | Oligonucleotide therapeutic agent and method of making same |
| US4452775A (en) * | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| US5075109A (en) * | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| DE4321946A1 (de) * | 1993-07-01 | 1995-01-12 | Hoechst Ag | Methylphosphonsäureester, Verfahren zu deren Herstellung und deren Verwendung |
| US5658738A (en) * | 1994-05-31 | 1997-08-19 | Becton Dickinson And Company | Bi-directional oligonucleotides that bind thrombin |
| EP1167378B1 (en) * | 1994-07-15 | 2011-05-11 | University of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| AU738513B2 (en) * | 1997-02-28 | 2001-09-20 | University Of Iowa Research Foundation, The | Use of nucleic acids containing unmethylated CpG dinucleotide in the treatment of LPS-associated disorders |
| EP1003531B1 (en) * | 1997-05-20 | 2007-08-22 | Ottawa Health Research Institute | Processes for preparing nucleic acid constructs |
| US6218371B1 (en) * | 1998-04-03 | 2001-04-17 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| DE60014076T2 (de) * | 1999-04-19 | 2005-10-13 | Glaxosmithkline Biologicals S.A. | Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid |
| EP1220684B2 (en) | 1999-09-27 | 2010-07-14 | Coley Pharmaceutical Group, Inc. | Methods related to immunostimulatory nucleic acid-induced interferon |
| US6949520B1 (en) | 1999-09-27 | 2005-09-27 | Coley Pharmaceutical Group, Inc. | Methods related to immunostimulatory nucleic acid-induced interferon |
| IL160157A0 (en) | 2001-08-17 | 2004-07-25 | Coley Pharm Group Inc | Combination motif immune stimulation oligonucleotides with improved activity |
| WO2006091915A2 (en) * | 2005-02-24 | 2006-08-31 | Coley Pharmaceutical Group, Inc. | Immunostimulatory oligonucleotides |
| JP2008535859A (ja) * | 2005-04-08 | 2008-09-04 | コーリー ファーマシューティカル グループ，インコーポレイテッド | 感染症によって悪化した喘息を治療するための方法 |
-
2008
- 2008-05-15 KR KR1020097026396A patent/KR20100010509A/ko not_active Ceased
- 2008-05-15 WO PCT/IB2008/001199 patent/WO2008142509A2/en not_active Ceased
- 2008-05-15 BR BRPI0811621-0A2A patent/BRPI0811621A2/pt not_active IP Right Cessation
- 2008-05-15 US US12/600,364 patent/US20100285041A1/en not_active Abandoned
- 2008-05-15 MX MX2009012482A patent/MX2009012482A/es unknown
- 2008-05-15 CN CN200880016477A patent/CN101678098A/zh active Pending
- 2008-05-15 AU AU2008252577A patent/AU2008252577A1/en not_active Abandoned
- 2008-05-15 RU RU2009142211/15A patent/RU2009142211A/ru not_active Application Discontinuation
- 2008-05-15 CA CA002687441A patent/CA2687441A1/en not_active Abandoned
- 2008-05-15 EP EP08750940A patent/EP2160199A2/en not_active Withdrawn
- 2008-05-16 AR ARP080102108A patent/AR066626A1/es unknown
- 2008-05-16 JP JP2008129762A patent/JP2009035530A/ja active Pending
- 2008-05-16 TW TW097118306A patent/TW200916115A/zh unknown
-
2009
- 2009-11-12 IL IL202096A patent/IL202096A0/en unknown
- 2009-11-16 ZA ZA200908062A patent/ZA200908062B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009035530A5 (enExample) | ||
| JP2020022453A5 (enExample) | ||
| JP2010029220A5 (enExample) | ||
| JP2006520339A5 (enExample) | ||
| JP2008540709A5 (enExample) | ||
| HRP20190995T1 (hr) | LIJEČENJE HBV-a | |
| JP2010525813A5 (enExample) | ||
| JP2012505657A5 (enExample) | ||
| JP2012528572A5 (enExample) | ||
| JP2011500769A5 (enExample) | ||
| JPWO2021055811A5 (enExample) | ||
| UA104131C2 (uk) | Модифікована ліпідом дволанцюжкова рнк, яка має сильний ефект рнк-інтерференції | |
| ATE414177T1 (de) | Oligonukleotide zur genotypisierung des thymidylat-synthase gens | |
| JP2013535212A5 (enExample) | ||
| WO2008005562A3 (en) | Rna silencing compositions and methods for the treatment of huntington's disease | |
| JP2009530257A5 (enExample) | ||
| JP2009530489A5 (enExample) | ||
| AU2011230496A8 (en) | Methods for enhancing nucleic acid hybridization | |
| WO2006126040A8 (en) | Bacterial and bacterial associated mirnas and uses thereof | |
| JP2010513358A5 (enExample) | ||
| JP2010532979A5 (enExample) | ||
| JP2013539967A5 (enExample) | ||
| NZ604094A (en) | Double stranded rna compounds to rhoa and use thereof | |
| JP2011509325A5 (enExample) | ||
| WO2009044085A3 (fr) | Oligonucleotides, utilisation, methode de detection et kit permettant de diganostiquer la presence du gene e1 du virus de chikungunya |